Search In this Thesis
   Search In this Thesis  
العنوان
USE OF B-TYPE NATRIURETIC PEPTIDE IN THE EVALUATION AND MANAGEMENT
OF ACUTE DYSPNEA\
الناشر
Ain Shams university.
المؤلف
Nawar,Ala’a Mahmoud.
هيئة الاعداد
مشرف / Sherien Ahmed Samy El-Masry
مشرف / Mervat Gamal Eldin Mansour
مشرف / Magda Yahia Al-Seify
باحث / Ala’a Mahmoud Nawar
الموضوع
B-TYPE. NATRIURETIC PEPTIDE. ACUTE DYSPNEA.
تاريخ النشر
2011
عدد الصفحات
p.:199
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
طب الأطفال ، الفترة المحيطة بالولادة وصحة الطفل
تاريخ الإجازة
1/1/2011
مكان الإجازة
جامعة عين شمس - كلية الطب - Pediatrics
الفهرس
Only 14 pages are availabe for public view

from 199

from 199

Abstract

Acute dyspnea is uncomfortable breathing occur within 24hours to 48hours in children but it is difficult to diagnosed as it has many causes.
Etiology of acute dyspnea can differentiated into cardiac, pulmonary and other causes as cardiac causes are more dangerous than others. Sometimes acute dyspnea may be mixed between cardiac and pulmonary this are more dangerous.
Management of acute dyspnea may be delayed until we reach the final diagnosis so we need rapid investigation to diagnose acute dyspnea.
B-type natriuretic peptide is laboratory investigation and is a cardiac neurohormone secreted from the ventricles in response to volume expansion and pressure overloads which can differentiate the causes of acute dyspnea into cardiac and non-cardiac causes fast enough to improve outcomes of patients and cost.
In our study, we measured BNP to 35 patients with acute dyspnea admitted to emergency room which found that 13 patients out of 35 patients have cardiac causes and 22 patients out of 35 patients have pulmonary causes.
Also in our study, we compared between group of patients who measured to them BNP and other group of patients who did not measure to them BNP which found that BNP measurement has a role in improvement of patients outcome (length of hospital stay, ICU admission, mechanical ventilation and fate) and cost.